Vivace Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series D

Recent Raise

$35M

Vivace Therapeutics is a company that develops small molecule drugs, focusing on a novel cancer therapeutic targeting the Hippo pathway for treating mesothelioma.